AmerisourceBergen raises FY13 continuing ops EPS view to $3.04-$3.14 Previous view was $2.96-$3.06. Consensus is $3.08. Due to the impact of the sale, AmerisourceBergen has revised its financial performance expectations for FY13. The company now expects revenue growth in the range of 8%-10%, consensus $86.17B. The revised EPS range does not include the impact of significant one-time expenses anticipated as a result of the previously disclosed new strategic long-term relationship with Walgreen Co. and Alliance Boots, GmbH, including a LIFO expense due to an anticipated inventory build and recurring non-cash expenses relating to the equity warrants issued in connection with the new relationship. The company continues to expect free cash flow in the range of $100M-$200M, and to repurchase approximately $400M of common stock in FY13.
AmerisourceBergen price target raised to $104 from $83 at Argus Argus increased its price target on AmerisourceBergen after the company reported stronger than expected Q4 results. The firm is confident in the company's ability to improve its profitability while sustaining its organic top-line growth in fiscal 2015. Argus keeps a Buy rating on the shares.